106 related articles for article (PubMed ID: 4076751)
21. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
[TBL] [Abstract][Full Text] [Related]
22. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.
Tondini C; Hayes DF; Gelman R; Henderson IC; Kufe DW
Cancer Res; 1988 Jul; 48(14):4107-12. PubMed ID: 3164256
[TBL] [Abstract][Full Text] [Related]
23. Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer.
Banki F; Yacoub WN; Hagen JA; Mason RJ; Ayazi S; DeMeester SR; Lipham JC; Danenberg K; Danenberg P; DeMeester TR
J Am Coll Surg; 2008 Jul; 207(1):30-5. PubMed ID: 18589358
[TBL] [Abstract][Full Text] [Related]
24. Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis.
Ebeling FC; Schmitt UM; Untch M; Nagel D; Fateh-Moghadam A; Stieber P; Seidel D
Anticancer Res; 1999; 19(4A):2545-50. PubMed ID: 10470192
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.
Lunde OC; Havig O
Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317
[TBL] [Abstract][Full Text] [Related]
26. [CA 15-3 and CEA as tumor markers in the diagnosis of the recurrence of breast cancer].
Engel K; Schmid H; Hanke J; Kaufmann M; Müller A
Geburtshilfe Frauenheilkd; 1988 May; 48(5):309-12. PubMed ID: 3165077
[TBL] [Abstract][Full Text] [Related]
27. [Tissue CEA as a prognostic factor in advanced and recurrent breast cancers].
Tsukikawa S; Kubota S; Biwata T; Shimomura T; Ohyama I; Nagashima T; Kanasugi K; Fukuda M; Yamaguchi S; Maruyama Y
Gan No Rinsho; 1986 Aug; 32(9):961-4. PubMed ID: 3747160
[TBL] [Abstract][Full Text] [Related]
28. [Cystosarcoma phylloides of the breast. A retrospective analysis of 12 cases].
Mallebré B; Ebert A; Perez-Cantó A; Hopp H; Opril F; Weitzel H
Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):35-40. PubMed ID: 8852784
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity of serum tumor markers CEA and CA 15-3 in breast cancer recurrences and correlation with different prognostic factors.
Lumachi F; Brandes AA; Ermani M; Bruno G; Boccagni P
Anticancer Res; 2000; 20(6C):4751-5. PubMed ID: 11205212
[TBL] [Abstract][Full Text] [Related]
30. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].
Willner J; Kiricuta IC; Kölbl O
Strahlenther Onkol; 1995 Jan; 171(1):18-28. PubMed ID: 7839301
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
32. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C
Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084
[TBL] [Abstract][Full Text] [Related]
33. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer].
Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA
Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982
[TBL] [Abstract][Full Text] [Related]
34. [Status of skeletal scintigraphy, lung roentgen image and liver sonography in the follow-up of breast cancer].
Schünemann H
Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):379-84. PubMed ID: 2661306
[TBL] [Abstract][Full Text] [Related]
35. [Our experience with the diagnostic and prognostic unreliability of pre- and postoperative CEA in human breast cancer].
Ovaleo-Pandolfo E; Capelli P; Franciosi V
Acta Biomed Ateneo Parmense; 1985; 56(2):91-8. PubMed ID: 2930984
[TBL] [Abstract][Full Text] [Related]
36. [Carcinoembryonic antigen (CEA) (author's transl)].
Staab HJ; Anderer FA; Stumpf E; Fischer R
Dtsch Med Wochenschr; 1977 Jul; 102(30):1082-6. PubMed ID: 891389
[TBL] [Abstract][Full Text] [Related]
37. Serial tests of carcinoembryonic antigen in patients with breast cancer.
Lee YT
Am J Clin Oncol; 1983 Jun; 6(3):287-93. PubMed ID: 6846246
[TBL] [Abstract][Full Text] [Related]
38. Carcinoembryonic antigen as a monitor of recurrent breast cancer.
Lee YT
J Surg Oncol; 1982 Jun; 20(2):109-14. PubMed ID: 7078191
[TBL] [Abstract][Full Text] [Related]
39. The role of carcinoembryonic antigen in the postmastectomy follow-up of primary breast cancer and in the prognostic evaluation of disseminated breast cancer.
Palazzo S; Liguori V; Molinari B; Greco LM; Mancini V
Tumori; 1984 Feb; 70(1):57-9. PubMed ID: 6710608
[TBL] [Abstract][Full Text] [Related]
40. Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients.
Molina R; Zanón G; Filella X; Moreno F; Jo J; Daniels M; Latre ML; Giménez N; Pahisa J; Velasco M
Breast Cancer Res Treat; 1995; 36(1):41-8. PubMed ID: 7579505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
